论文部分内容阅读
目的探讨人绒毛膜促性腺激素(human chorionic gonadotropin,HCG)对复发性卵巢子宫内膜异位症的治疗效果。方法选择经腹或腹腔镜手术治疗后复发的卵巢子宫内膜异位症患者16例,给予HCG肌内注射2000U,每周一次,疗程3个月,评估治疗后卵巢子宫内膜异位囊肿的情况、患者痛经程度的改善、雌激素(E2)的水平变化并记录分析治疗期间的副反应。结果治疗3个月后,卵巢子宫内膜异位囊肿的体积较治疗前缩小(P<0.05);患者对痛经的视觉模拟评分较治疗前降低(P<0.05);E2的数值与治疗前差异无统计学意义(P>0.05),有3例患者出现恶心。结论 HCG对复发性卵巢子宫内膜异位症具有一定治疗效果,并且副反应少。
Objective To investigate the therapeutic effect of human chorionic gonadotropin (HCG) on recurrent ovarian endometriosis. Methods Sixteen patients with ovarian endometriosis who recurred after transabdominal or laparoscopic surgery were given intramuscular injection of HCU (2000U) once a week for 3 months to evaluate the effect of ovarian endometriosis The condition, the degree of dysmenorrhea in the patient, the level of estrogen (E2), and the side effects during treatment were recorded. Results After 3 months of treatment, the volume of ovarian endometriotic cyst decreased compared with that before treatment (P <0.05), and the visual analog scale of dysmenorrhea was lower than that before treatment (P <0.05) No statistical significance (P> 0.05), 3 patients had nausea. Conclusion HCG has a certain therapeutic effect on recurrent ovarian endometriosis with fewer side effects.